ONTX Onconova Therapeutics is falling or rising technical reasons. Technical analysis forecast of Onconova Therapeutics Stock is that its in a uptrend for. You can watch ONTX and buy and sell other stock and options commission-free on Robinhood. Change the date range, see whether others are buying or selling. The Investor Relations website contains information about Onconova Therapeutics's business for stockholders, potential investors, and financial analysts. ONTX | Complete Ontex Group N.V. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. On Friday 08/23/ the closing price of the Onconova Therapeutics Inc Registered Shs share was $ on BTT. Compared to the opening price on Friday 08/23/.
Sarepta sees a significant surge in its stock price. The Dow Jones rises while the S&P falls and AI stocks extend losses. Nvidia stock stumbles but the. Onconova Therapeutics (ONTX) News Today Notice: This company has been marked as potentially delisted and may not be actively trading. TRAW Traws Pharma, Inc. Onconova Therapeutics was incorporated in in Delaware and began trading on the NASDAQ stock exchange under the ticker symbol ONTX in July, Latest. Onconova Therapeutic stocks price quote with latest real-time prices Most Recent Stories. More News · Onconova Therapeutics to Provide Corporate. Stock price for similar companies or competitors ; Onconova Therapeutics Logo · Spectrum Pharmaceuticals. SPPI. $, % ; Onconova Therapeutics Logo · Array. Oops, something went wrong. Check your browser's developer console for more details. Stock Information. Stock Quote (). Previous Close. Open. Volume. Stock Information · Stock Quote () · Stock Chart · Investor Relations · Shareholder Tools · Search Investor Relations. Over the last year, Onconova Therapeutics shares have traded in a share price range of US$ to US$ Onconova Therapeutics currently has 21,, Onconova Therapeutics is now traded for The entity stock is not elastic to its hype. The average elasticity to hype of competition is Onconova is. Onconova Therapeutics (ONTX) reported Q3 earnings per share (EPS) of -$, beating estimates of -$ by %. In the same quarter last year, Onconova. Sarepta sees a significant surge in its stock price. The Dow Jones rises while the S&P falls and AI stocks extend losses. Nvidia stock stumbles but the.
Onconova Therapeutics Inc. · 5 Stocks Under $10 That Could Rocket Higher Soon · 7 stocks under $10 making big up moves · 3 Stocks Driving The Drugs Industry Higher. Onconova Therapeutics released its earnings results on Mar 07, The company reported -$ earnings per share for the quarter, missing the consensus. In the current month, ONTX has received 3 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. ONTX average Analyst price target in the past 3 months is $ The 7 analysts offering price forecasts for Onconova Therapeutics have a median target of , with a high estimate of and a low estimate of The. The average one-year price target for Onconova Therapeutics, Inc. is $ The forecasts range from a low of $ to a high of $ The share price of Onconova Therapeutics, Inc. as of April 2, is $ / share. The Factor Analysis chart (below right) shows a view of Onconova. Profitability Metrics. Gross Margin (ttm). % ; Revenue and Earnings Metrics. Revenue (ttm). $, ; Cash and Debt Metrics. Total Cash. $M. This company seems to have been delisted. Reason: Merged with Trawsfynydd Therapeutics to form Traws Pharma Last recorded trade on: June 5, Announces Pricing of $25 Million Public Offering of Common Stock NEWTOWN, Pa., Feb. 10, (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX) (“.
Stock Price, News, Quote and Profile of ONCONOVA THERAPEUTICS INC(NASDAQ:ONTX) stock. General stock ratings, overview and activity description. Why Onconova Therapeutics Inc. Shares Imploded Onconova Therapeutics reported disappointing phase 3 results for high-risk myelodysplastic syndrome drug. Onconova Therapeutics Inc Similar Stocks · Market price · (%). TRAW News · Traws Pharma files to sell about M shares by holders · Onconova Therapeutics GAAP EPS of -$ beats by $, revenue of $M in-line. Earnings for Onconova Therapeutics are expected to decrease in the coming year, from ($) to ($) per share. Price to Earnings Ratio vs. the Market. The P.
“The Buzz'' Show: Onconova Therapeutics Inc (NASDAQ: ONTX) Anti-Cancer Clinical Data
View Onconova Therapeutics, Inc. (ONTXW) stock price, news, historical charts, analyst ratings, financial information and quotes on Moomoo. ONTX News Highlights · For ONTX, its 30 day story count is now at 2. · Over the past 4 days, the trend for ONTX's stories per day has been choppy and unclear. It. News & Research. Profile. Home · Dividend Stocks · Health Care · Biotech Pharma · Biotech; Onconova Therapeutics, Inc. (ONTX). Dividend Data. Stock Data. Avg. Discover real-time Traws Pharma, Inc. Common Stock (TRAW) stock prices, quotes, historical data, news, and Insights for informed trading and investment.
Fastest Way To Become A Billionaire | Options Order Flow Software